GD1b Antibody
GD1b antibody is a biomarker used to detect the presence of antibodies against the GD1b ganglioside, which is found in nerve cell membranes.
GD1b antibody titer helps diagnose neurological disorders associated with anti-GD1b antibodies.
Key facts at a glance
- Units
- titer
- Clinical utility
- diagnostic
- Result kind
- qualitative
- FDA-cleared
- Roche Anti-GD1b, Athersys GD1b Ab
GD1b is a ganglioside, a type of glycosphingolipid, that is abundant in the nervous system. Antibodies against GD1b can be indicative of certain neurological conditions.
The measurement of GD1b antibody titers is primarily used to aid in the diagnosis of autoimmune neuropathies, such as Guillain-Barré syndrome and its variants.
Elevated levels of GD1b antibodies, particularly those exceeding a titer of 1, may suggest the presence of these neurological disorders.
Frequently asked questions
What is the significance of elevated GD1b antibody levels?
How is the GD1b antibody test performed?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy